Ryan Pardo - 10 Nov 2026 Form 4 Insider Report for LifeStance Health Group, Inc. (LFST)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
13 Nov 2026, 21:05:03 UTC
Prior SEC filing
03 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: /s/ Ryan Pardo
Filing notes and source

Key filing fact

Ryan Pardo filed Form 4 for LifeStance Health Group, Inc. (LFST) on 13 Nov 2026.

Key facts

  • This page summarizes Ryan Pardo's Form 4 filing for LifeStance Health Group, Inc. (LFST).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 13 Nov 2026, 21:05.

Change

  • Previous filing in this sequence was filed on 03 Apr 2026.
  • Current net transaction value: -$40,889,683.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001865531 Primary reporting owner

Pardo Ryan

Relationship
Chief Legal Officer and Secretary
Address
C/O LIFESTANCE HEALTH GROUP, INC., 4800 N. SCOTTSDALE ROAD, SUITE 2500, SCOTTSDALE
Signature
By: /s/ Ryan Pardo
Signature date
13 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LFST transaction

Common Stock

Sale

Transaction value
-$8,571,874
Shares
-587,920
Change %
-54%
Price
$14.58
Shares after
505,446
Date
10 Nov 2026
Ownership
Direct
Footnotes
F1, F2
LFST transaction

Common Stock

Sale

Transaction value
-$32,317,809
Shares
-2,216,585
Change %
-87%
Price
$14.58
Shares after
334,935
Date
10 Nov 2026
Ownership
By Trust
Footnotes
F3, F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 5 footnotes

Footnote F1

The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $14.285 to $14.7878 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Footnote F2

Represents shares sold pursuant to a plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) that was adopted on August 11, 2026.

Footnote F3

Represents shares sold pursuant to a plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) that was adopted on August 10, 2026.

Footnote F4

The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $14.285 to $14.7878 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Footnote F5

Shares held of record by Kimberly Pardo Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities and Exchange Act of 1934 or for any other purpose.

SEC remarks

Chief Legal Officer and Secretary

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .